Skip to main content
. 2022 Sep 2;9:977287. doi: 10.3389/fnut.2022.977287

Table 2.

Evaluation of the benefits of combined extracts in mice by the open field test (OFT) and the forced swimming test (FST).

Group (n = 8) a,b Positive control Control Low dose Medium dose High dose
Open field test Frequency 11.38 ± 1.16 9.50 ± 1.34 10.25 ± 0.82 10.75 ± 1.08 11.25 ± 0.56
Duration time (sec) 17.63 ± 1.13 12.13 ± 1.20 14.75 ± 1.69 16.63 ± 1.85 17.25 ± 1.45
Distance traveled (mm) 691 ± 110.51 371.71 ± 66.74 447.05 ± 56.74 627.85 ± 72.00 663.38 ± 88.65
Velocity (mm/s) 29.85 ± 4.15 18.18 ± 1.93 18.84 ± 1.36 19.25 ± 2.12 20.20 ± 3.14
Forced swimming test Immobility time (sec) 207.58 ± 12.32 254.83 ± 13.81 228.35 ± 12.41 216.45 ± 8.17 210.51 ± 10.89
a

Data are expressed as the mean ± S.E.M. (n = 8) and analyzed by one-way ANOVA.

b

Data points were not significantly different (p > 0.05) from each other according to ANOVA. Positive control: CORT (40 mg/kg/day) + Fluoxetine (20 mg/kg/day). Control: CORT (40 mg/kg/day). Low dose: CORT (40 mg/kg/day) + combined extracts of chlorella and lion's mane mushroom (contains 0.1 mL chlorella extract concentrate + 6 mg lion's mane mushroom extract concentrate). Medium dose: CORT (40 mg/kg/day) + combined extracts of chlorella and lion's mane mushroom (contains 0.2 mL chlorella extract concentrate + 12 mg lion's mane mushroom extract concentrate). High dose: CORT (40 mg/kg/day) + combined extracts of chlorella and lion's mane mushroom (contains 0.4 mL chlorella extract concentrate + 24 mg lion's mane mushroom extract concentrate).